首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1390611

荷爾蒙避孕市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Hormonal Contraceptive Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年，全球荷爾蒙避孕藥市場規模達到179億美元。展望未來， IMARC Group預計到2028年市場規模將達到229億美元，2022-2028年複合年成長率（CAGR）為4.19%。

荷爾蒙避孕藥是孕激素或雌激素和黃體激素組合的製劑。它們作用於內分泌系統以阻止排卵和受精。因此，它們被用於預防意外懷孕，並且還可以緩解經期疼痛，並且通常會導致月經量減少。荷爾蒙避孕藥被認為是最有效的方法之一，可以在陰道性交前後服用。它們包括避孕藥、陰道環、避孕皮膚貼片和釋放荷爾蒙的避孕線圈。荷爾蒙避孕藥也會影響子宮內膜，使受精卵難以著床。

荷爾蒙避孕藥市場趨勢：

全球荷爾蒙避孕藥市場主要是由大眾計劃生育意識的提高所推動的。這促進了防止意外懷孕的需要，特別是在年輕夫婦中。此外，與少女懷孕相關的健康問題顯著增加，促進了避孕藥具的使用，因為它們很容易獲得。不同國家的政府也正在採取各種舉措，透過促進負擔得起的高品質醫療保健服務來支持和改善這些產品的取得。除此之外，醫療保健產業的進步催生了荷爾蒙貼片、植入物、子宮內避孕器和藥物器材組合產品等創新產品的生產。這些設備副作用較少，預防懷孕的效率提高，對市場的成長產生了有利的影響。

本報告回答的關鍵問題：

迄今為止，全球荷爾蒙避孕藥市場表現如何，未來幾年將如何表現？
COVID-19 對全球荷爾蒙避孕藥市場有何影響？
主要區域市場有哪些？
基於產品的市場區隔是什麼？
基於荷爾蒙的市場區隔是什麼？
市場按年齡層分類是怎樣的？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球荷爾蒙避孕藥市場的結構如何？誰是主要參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Afaxys Inc.
- Agile Therapeutics Inc.
- Allergan Inc. (AbbVie Inc.)
- Bayer AG
- Cipla Limited
- Johnson & Johnson
- Merck & Co. Inc.
- Pfizer Inc.
- Piramal Group
- Teva Pharmaceutical Industries Ltd

簡介目錄圖表

Product Code: SR112023A4403

Abstract

The global hormonal contraceptive market size reached US$ 17.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.9 Billion by 2028, exhibiting a growth rate (CAGR) of 4.19% during 2022-2028.

Hormonal contraceptives are formulations of progestin or a combination of estrogen and progesterone hormones. They act on the endocrine system to prevent ovulation and fertilization. As a result, they are used for preventing unwanted pregnancies and are also known to relieve period pain and often result in lighter periods. Hormonal contraceptives are considered one of the most effective methods, which can be taken before and after vaginal intercourse. They include birth control pills, vaginal rings, contraceptive skin patches, and hormone-releasing contraceptive coils. Hormonal contraceptives also affect the womb lining, making it hard for the fertilized eggs to be implanted.

Hormonal Contraceptive Market Trends:

The global hormonal contraceptive market is primarily driven by the increasing awareness among the masses regarding family planning. This has facilitated the need to prevent unintended pregnancies, especially among young couples. Furthermore, a significant rise in health issues associated with teenage pregnancies is promoting the use of contraceptives as they are easily accessible. Governments of different countries are also adopting various initiatives to support and improve access to these products by promoting affordable and high-quality healthcare services. Besides this, the advancements in the healthcare industry have resulted in the production of innovative products such as hormonal patches, implants, intrauterine devices, and drug-device combination products. These devices have fewer side effects and enhanced levels of efficiency in preventing pregnancy, which is favorably influencing the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hormonal contraceptive market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, hormone, age group and end user.

Breakup by Product:

Oral Contraceptive Pills

Intrauterine Device (IUD)

Injectable Birth Control

Vaginal Rings

Others

Breakup by Hormone:

Progestin-only Contraceptive

Combined Hormonal Contraceptive

Breakup by Age Group:

15-24 Years

25-34 Years

35-44 Years

Above 44 Years

Breakup by End User:

Hospitals and Clinics

Homecare

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Afaxys Inc., Agile Therapeutics Inc., Allergan Inc. (AbbVie Inc.), Bayer AG, Cipla Limited, Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Piramal Group and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

How has the global hormonal contraceptive market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global hormonal contraceptive market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the hormone?
What is the breakup of the market based on the age group?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global hormonal contraceptive market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Hormonal Contraceptive Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Oral Contraceptive Pills
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Intrauterine Device (IUD)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Injectable Birth Control
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Vaginal Rings
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Hormone

7.1 Progestin-only Contraceptive
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Combined Hormonal Contraceptive
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Age Group

8.1 15-24 Years
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 25-34 Years
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 35-44 Years
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Above 44 Years
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Homecare
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Ambulatory Surgical Centers
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Afaxys Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Agile Therapeutics Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Allergan Inc. (AbbVie Inc.)
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Bayer AG
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Cipla Limited
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Johnson & Johnson
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Merck & Co. Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Pfizer Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Piramal Group
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
- 15.3.10 Teva Pharmaceutical Industries Ltd
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Hormonal Contraceptive Market: Major Drivers and Challenges
Figure 2: Global: Hormonal Contraceptive Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Hormonal Contraceptive Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Hormonal Contraceptive Market: Breakup by Product (in %), 2022
Figure 5: Global: Hormonal Contraceptive Market: Breakup by Hormone (in %), 2022
Figure 6: Global: Hormonal Contraceptive Market: Breakup by Age Group (in %), 2022
Figure 7: Global: Hormonal Contraceptive Market: Breakup by End User (in %), 2022
Figure 8: Global: Hormonal Contraceptive Market: Breakup by Region (in %), 2022
Figure 9: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Hormonal Contraceptive (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Hormonal Contraceptive (Intrauterine Device-IUD) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Hormonal Contraceptive (Injectable Birth Control) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Hormonal Contraceptive (Injectable Birth Control) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Hormonal Contraceptive (Vaginal Rings) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Hormonal Contraceptive (Vaginal Rings) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Hormonal Contraceptive (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Hormonal Contraceptive (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Hormonal Contraceptive (Progestin-only Contraceptive) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Hormonal Contraceptive (Combined Hormonal Contraceptive) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Hormonal Contraceptive (15-24 Years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Hormonal Contraceptive (15-24 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Hormonal Contraceptive (25-34 Years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Hormonal Contraceptive (25-34 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Hormonal Contraceptive (35-44 Years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Hormonal Contraceptive (35-44 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Hormonal Contraceptive (Above 44 Years) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Hormonal Contraceptive (Above 44 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Hormonal Contraceptive (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Hormonal Contraceptive (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Hormonal Contraceptive (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Hormonal Contraceptive (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Hormonal Contraceptive (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Hormonal Contraceptive (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Hormonal Contraceptive (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: North America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: North America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: United States: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: United States: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Canada: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Canada: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Asia-Pacific: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Asia-Pacific: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: China: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: China: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Japan: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Japan: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: India: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: India: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: South Korea: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: South Korea: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Australia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Australia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Indonesia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Indonesia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Europe: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Europe: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Germany: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Germany: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: France: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: France: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: United Kingdom: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: United Kingdom: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Italy: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Italy: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Spain: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Spain: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Russia: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Russia: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Latin America: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Latin America: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Brazil: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Brazil: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Mexico: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Mexico: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Others: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Others: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Middle East and Africa: Hormonal Contraceptive Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Middle East and Africa: Hormonal Contraceptive Market: Breakup by Country (in %), 2022
Figure 87: Middle East and Africa: Hormonal Contraceptive Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Global: Hormonal Contraceptive Industry: SWOT Analysis
Figure 89: Global: Hormonal Contraceptive Industry: Value Chain Analysis
Figure 90: Global: Hormonal Contraceptive Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Hormonal Contraceptive Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Hormonal Contraceptive Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Hormonal Contraceptive Market Forecast: Breakup by Hormone (in Million US$), 2023-2028
Table 4: Global: Hormonal Contraceptive Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
Table 5: Global: Hormonal Contraceptive Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Hormonal Contraceptive Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Hormonal Contraceptive Market: Competitive Structure
Table 8: Global: Hormonal Contraceptive Market: Key Players

02-2729-4219

+886-2-2729-4219